Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveM&A3 Aug 2026

Park Medi World Ltd

Acquisition of Mehar Hospital Zirakpur

Park Medi World Ltd has announced the acquisition of Mehar Hospital Zirakpur, owned and operated by Mehar Mediserve LLP, and has also approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win3 Aug 2026

HBL Engineering Ltd-$

HBL has accepted an order worth Rs.31.49 crores (excluding 18% GST) from Intergal Coach Factory, Chennai for supply, installation, testing and commissioning of on-baord Kavach Loco equipment (ver 4.0)

HBL Engineering Ltd has accepted an order worth Rs. 31.49 Crores from Integral Coach Factory (ICF), Chennai for supply, installation, testing and commissioning of On-board KAVACH Loco equipment (Ver.4.0). The contract is to be completed on or before 31 March 2028.

Read more →📎 1 attachment
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win3 Aug 2026

HBL Engineering Limited

Bagging/Receiving of orders/contracts

HBL Engineering Limited has received an order worth Rs. 31.49 Crores from Integral Coach Factory (ICF), Chennai for the supply, installation, testing, and commissioning of On-board KAVACH Loco equipment (Ver. 4.0).

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults3 Aug 2026

TVS Motor Company Ltd

Sales update for the month of July 2026

TVS Motor Company Ltd reported its highest ever monthly sales of 6.30 Lakh units in July 2026, with a 38% growth compared to the same period last year. The company's two-wheeler EV sales grew by 158% and international business sales grew by 29%.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults3 Aug 2026

Bajaj Auto Limited

Press Release

Bajaj Auto Limited has released a press statement announcing sales figures for July 2026, showing a 19% increase in domestic two-wheeler sales, a 42% increase in exports, and a 30% increase in total sales compared to the same period last year. The company's commercial vehicle sales also saw a 24% increase in domestic sales and a 22% increase in exports.

Read more →📎 1 attachment
NSEMonthly Business Updates▲ PositiveOrder Win3 Aug 2026

TVS Motor Company Limited

Monthly Business Updates

TVS Motor Company has reported its highest ever monthly sales of 6.30 lakh units in July 2026, with a 38% growth in total two-wheelers and 158% growth in electric vehicle sales.

Read more →📎 1 attachment
NSEPress Release (Revised)▲ PositiveResults3 Aug 2026

Vishnu Chemicals Limited

Press Release (Revised)

Vishnu Chemicals Limited reported a strong Q1FY27 performance with revenue and profits growing over 20% YoY, driven by strong execution and operational resilience. The company's diversified revenue mix and strategic shift towards higher-value-added derivatives contributed to the growth.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults3 Aug 2026

Vishnu Chemicals Ltd

Revised Q1FY27 Earnings Release is enclosed

Vishnu Chemicals Ltd reported its unaudited financial results for Q1FY27, with revenue, EBITDA, and PAT growing by 24.9%, 22.6%, and 23.0% YoY, respectively. The company delivered a robust performance, with strong execution and operational resilience.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win3 Aug 2026

Adani Ports and Special Economic Zone Ltd

Operational performance update

Adani Ports and Special Economic Zone Ltd reported a 15% YoY growth in cargo volume to 46.3 MMT in July 2026, led by growth across all cargo categories, including dry cargo which grew 21% YoY. Year-to-date, the company handled 184.4 MMT cargo, a 15% YoY growth, driven by containers and dry cargo. Logistics rail volume in July 2026 was 51,020 TEUs, a 5% sequential growth but a 16% YoY decline.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults3 Aug 2026

Sarda Energy & Minerals Ltd-$

Investor Presentation for Q1/FY27

Sarda Energy & Minerals Ltd. has released its Q1 FY27 investor presentation, highlighting a 9.4% YoY growth in EBITDA and a 11% YoY growth in cash profit. The company's energy segment contributed nearly 70% to consolidated EBITDA, driven by stable PLF and improved realization. Hydropower generation was temporarily impacted by a shutdown at the Sikkim plant, while mining operations continued to support operating performance. The company has also announced a one-time net benefit of Rs. 110 crore relating to the regulatory approval of final project cost for the Sikkim Hydropower Plant.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults3 Aug 2026

Ashok Leyland Ltd

Monthly sales volume for the month of July 2026

Ashok Leyland Ltd has announced its monthly sales volume for July 2026, with a 33% increase in domestic sales and a 30% increase in exports. The company sold 17,980 vehicles in the domestic market and 19,590 vehicles in the domestic and export markets combined.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A3 Aug 2026

Biocon Limited

Press Release

Biocon Limited has announced the commercial launch of Yesafili, a biosimilar to Regeneron's Eylea 2 mg, in the United States. The product was approved by the U.S. FDA in May 2024 and has been granted interchangeable designation, allowing substitution at the pharmacy level in accordance with state laws.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveProduct Launch3 Aug 2026

Biocon Limited

General Updates

Biocon Limited has announced the commercial launch of Yesafili™, a biosimilar to Eylea 2 mg, in the United States. The product was approved by the U.S. FDA and granted interchangeable designation, allowing substitution at the pharmacy level. The launch is expected to benefit approximately 20 million adults in the U.S. with age-related macular degeneration and other serious eye conditions.

Read more →📎 1 attachment
BSECompany Update▲ PositiveProduct Launch3 Aug 2026

Biocon Ltd

Press Release

Biocon Ltd has announced the commercial launch of Yesafili, a biosimilar to Eylea 2 mg, in the United States. The product is a vascular endothelial growth factor (VEGF) inhibitor used to treat various types of ophthalmology conditions.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win3 Aug 2026

Biocon Ltd

Commercial Launch of Product

Biocon Ltd has commercially launched Yesafili, a biosimilar Aflibercept, in the United States, expanding its global presence in ophthalmology and increasing access to life-changing medicines for patients with eye conditions.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults2 Aug 2026

EPack Prefab Technologies Limited

Analysts/Institutional Investor Meet/Con. Call Updates

EPack Prefab Technologies Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a revenue growth of 23.9% YoY to ₹3,658 Mn. The company's EBITDA and PAT margins have also improved, with EBITDA margin at 9.4% and PAT margin at 5.0%. The order book has increased by 146.4% YoY to ₹13,764 Mn. The company has reaffirmed its A+ credit rating.

Read more →📎 1 attachment
← PreviousPage 778 of 995Next →